NCT03432546

Brief Summary

Approximately 20,000 patients are treated in intensive care units (ICU) in Finland annually. During ICU stay many diagnostic and other procedures as well as immobilization and underlying diseases may cause pain. Therefore the incidence of pain in ICU patients can be high. Acute pain may cause several detrimental effects including respiratory distress, tissue hypoxia, immunosuppression and anxiety. After discharge many survivors of critical care have lower health-related quality of life, symptoms of post-traumatic stress disorder or persistent pain. Only few studies with a focus on acute or persistent pain in ICU patients have been made, hence the incidence and risk factors for ICU-related pain is not very well known. Some of the identified risk factors for persisting pain may be increased age, sepsis or inadequate pain management during ICU stay. Opioids are most often used for analgesics in intensive care. Because they may have several adverse effects the use must be based on validated pain scales. Many factors such as sedation, relaxation or delirium of the patient complicates the management of the pain. This prospective observational study aims to determine the incidence and risk factors for acute and persistent pain in ICU patients as well as and the use of analgesics during intensive care.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
707

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Apr 2018

Typical duration for all trials

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 20, 2017

Completed
2 months until next milestone

First Posted

Study publicly available on registry

February 14, 2018

Completed
2 months until next milestone

Study Start

First participant enrolled

April 6, 2018

Completed
3.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2021

Completed
Last Updated

October 5, 2022

Status Verified

October 1, 2022

Enrollment Period

3.7 years

First QC Date

December 20, 2017

Last Update Submit

October 3, 2022

Conditions

Outcome Measures

Primary Outcomes (3)

  • Incidence of acute pain

    Moderate or severe pain (numerical rating scale (NRS) value above 3 / critical pain observatory tool (CPOT) value ≥3) during intensive care

    Through study completion, an average of 3 days

  • Incidence of persistent neuropathic pain using Pain Detect

    Moderate or severe pain.

    At intensive care follow up clinic at three months after discharge and thereafter the change in pain annually for 5 years

  • Incidence of anxiety affecting persistent pain

    State Trait anxiety Index T (STAI-T)

    At intensive care follow up clinic at three months after discharge and thereafter the change in anxiety annually for 5 years

Secondary Outcomes (2)

  • Analgesic use

    Through study completion, an average of 3 days

  • Delirium

    Through study completion, an average of 3 days

Study Arms (1)

ICU patients

Over 18-year old intensive care patients, non-interventional prospective observational study

Other: Non-interventional

Interventions

Non-interventional

ICU patients

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Prospective cohort of intensive care patients

You may not qualify if:

  • pregnant patients
  • age under 18 years
  • suffering from significant brain injury
  • elective neurosurgical patients
  • probable organ donors
  • suffering from significant cognitive impairment
  • presumed death under 48h

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Helsinki University Central Hospital, Meilahti

Helsinki, Finland

Location

Tampere University Hospital

Tampere, Finland

Location

MeSH Terms

Conditions

Acute PainChronic Pain

Condition Hierarchy (Ancestors)

PainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Maija-Liisa Kalliomäki

    Tampere University Hospital

    STUDY CHAIR
  • Otto Mäkinen

    Tampere University

    STUDY CHAIR
  • Sari Karlsson

    Tampere University Hospital

    STUDY CHAIR
  • Simo Varila

    Tampere University Hospital

    STUDY CHAIR
  • Minna Peltomaa

    Tampere University Hospital

    STUDY CHAIR
  • Karita Koskinen

    HUS

    STUDY CHAIR
  • Anna-Maria Kuivalainen

    HUS

    STUDY CHAIR
  • Katri Hamunen

    HUS Pain Clinic

    STUDY CHAIR
  • Minna Bäcklund

    HUS

    STUDY CHAIR
  • Sari Sutinen

    HUS

    STUDY CHAIR
  • Leena Pettilä

    HUS

    STUDY CHAIR
  • Annika Laukkanen

    Töölö Hospital

    STUDY CHAIR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 20, 2017

First Posted

February 14, 2018

Study Start

April 6, 2018

Primary Completion

December 31, 2021

Study Completion

December 31, 2021

Last Updated

October 5, 2022

Record last verified: 2022-10

Data Sharing

IPD Sharing
Will not share

Locations